Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 12.14
(3.67%)
INR 12.14
(3.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 175.16 Million INR | -9.34% |
| 2022 | 193.21 Million INR | -4.05% |
| 2021 | 201.36 Million INR | 11.83% |
| 2020 | 180.07 Million INR | -16.17% |
| 2019 | 214.79 Million INR | 26.67% |
| 2018 | 169.57 Million INR | -19.8% |
| 2017 | 211.44 Million INR | -15.47% |
| 2016 | 250.13 Million INR | 65.06% |
| 2015 | 151.54 Million INR | 22.79% |
| 2014 | 123.42 Million INR | 148.57% |
| 2013 | 49.65 Million INR | -14.7% |
| 2012 | 58.21 Million INR | -4.5% |
| 2011 | 60.95 Million INR | 24.78% |
| 2010 | 48.84 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -404.62 Million INR | -330.99% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 175.16 Million INR | -9.34% |
| 2023 Q4 | 175.16 Million INR | 0.0% |
| 2023 Q2 | 176.93 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 193.21 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 193.21 Million INR | -4.05% |
| 2022 Q2 | 213.46 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 201.36 Million INR | 0.0% |
| 2021 Q2 | 190.88 Million INR | 0.0% |
| 2021 FY | 201.36 Million INR | 11.83% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | 152.05 Million INR | 3.64% |
| 2020 Q4 | 180.07 Million INR | 18.43% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 180.07 Million INR | -16.17% |
| 2020 Q2 | 146.71 Million INR | 0.0% |
| 2019 Q4 | 214.79 Million INR | 0.0% |
| 2019 FY | 214.79 Million INR | 26.67% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 135.77 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 169.57 Million INR | -19.8% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 169.57 Million INR | 0.0% |
| 2018 Q2 | 195.87 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 211.44 Million INR | -15.47% |
| 2017 Q4 | 211.44 Million INR | 0.0% |
| 2017 Q2 | 318.8 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 250.13 Million INR | 65.06% |
| 2016 Q4 | 251.09 Million INR | 50.23% |
| 2016 Q3 | 167.14 Million INR | 14.21% |
| 2016 Q2 | 146.34 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 151.54 Million INR | 22.79% |
| 2015 Q2 | 129.08 Million INR | 0.0% |
| 2015 Q4 | 151.54 Million INR | -2.69% |
| 2015 Q3 | 155.73 Million INR | 20.65% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 103.01 Million INR | 0.0% |
| 2014 FY | 123.42 Million INR | 148.57% |
| 2014 Q4 | 123.42 Million INR | 34.23% |
| 2014 Q3 | 91.94 Million INR | -10.75% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 49.65 Million INR | 0.0% |
| 2013 FY | 49.65 Million INR | -14.7% |
| 2012 FY | 58.21 Million INR | -4.5% |
| 2012 Q4 | 58.21 Million INR | 0.0% |
| 2011 FY | 60.95 Million INR | 24.78% |
| 2011 Q4 | 60.95 Million INR | 0.0% |
| 2010 FY | 48.84 Million INR | 0.0% |
| 2010 Q4 | 48.84 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -581.555% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 82.419% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -734.526% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -226.518% |
| Sunil Healthcare Limited | 902.83 Million INR | 80.598% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -8131.532% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.773% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 82.559% |
| Patidar Buildcon Limited | 25.57 Million INR | -584.995% |
| Roopa Industries Limited | 493.08 Million INR | 64.475% |
| Smruthi Organics Limited | 485.72 Million INR | 63.937% |
| Trident Lifeline Limited | 331.26 Million INR | 47.121% |
| PANJON LTD. | 25.38 Million INR | -590.096% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 15.963% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -8.346% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -1069.417% |
| Anuh Pharma Limited | 1.54 Billion INR | 88.66% |
| Crestchem Limited | 23.94 Million INR | -631.478% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1206.729% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -48.167% |
| Tyche Industries Limited | 101.64 Million INR | -72.339% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 90.589% |
| Trimurthi Limited | 101.36 Thousand INR | -172716.693% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 13.273% |
| Norris Medicines Limited | 278.17 Million INR | 37.03% |
| Zenlabs Ethica Limited | 301.35 Million INR | 41.873% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 39.903% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 89.458% |
| Parmax Pharma Limited | 117.56 Million INR | -48.992% |
| Veerhealth Care Limited | 62.78 Million INR | -179.017% |
| Deccan Health Care Limited | 111.33 Million INR | -57.332% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 89.781% |
| Makers Laboratories Limited | 569.18 Million INR | 69.225% |
| Lactose (India) Limited | 536.39 Million INR | 67.344% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 78.975% |
| Zenith Healthcare Limited | 24.03 Million INR | -628.8% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -12.964% |
| Bacil Pharma Limited | 1.12 Million INR | -15415.235% |
| PRAVEG LIMITED | 767.53 Million INR | 77.178% |
| Denis Chem Lab Limited | 289.82 Million INR | 39.56% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 89.794% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 13.108% |
| Colinz Laboratories Limited | 24.1 Million INR | -626.683% |
| Godavari Drugs Limited | 957.86 Million INR | 81.713% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -58484.281% |
| Zenotech Laboratories Limited | 156.64 Million INR | -11.822% |
| Panchsheel Organics Limited | 340.2 Million INR | 48.511% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 64.132% |
| Vivanza Biosciences Limited | 148.63 Million INR | -17.854% |
| Phaarmasia Limited | 211.49 Million INR | 17.177% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 88.327% |
| Medi-Caps Limited | 63.01 Million INR | -177.972% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -48.793% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 11.251% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 84.511% |
| Mercury Laboratories Limited | 171.18 Million INR | -2.324% |
| Gennex Laboratories Limited | 535.21 Million INR | 67.271% |
| BDH Industries Limited | 312.53 Million INR | 43.953% |
| Coral Laboratories Limited | 281.83 Million INR | 37.849% |
| Concord Drugs Limited | 249.88 Million INR | 29.901% |
| Bharat Parenterals Limited | 2.65 Billion INR | 93.406% |
| Beryl Drugs Limited | 85.63 Million INR | -104.548% |
| Evoq Remedies Limited | 116.23 Million INR | -50.705% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -10.027% |
| Transchem Limited | 6.72 Million INR | -2506.652% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1874.38% |
| Parnax Lab Limited | 1.17 Billion INR | 85.038% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -317.343% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 83.438% |
| Cian Healthcare Limited | 1.03 Billion INR | 83.065% |
| Trinity League India Limited | 876 Thousand INR | -19896.233% |
| Syschem (India) Limited | 1.07 Billion INR | 83.64% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 91.426% |
| Natural Capsules Limited | 1.47 Billion INR | 88.142% |
| Auro Laboratories Limited | 433.09 Million INR | 59.555% |